| Dr Sohail Mehmood, MD | |
|
610 30th Ave W, Alexandria, MN 56308-3426 | |
| (320) 763-5123 | |
| (320) 763-7883 |
| Full Name | Dr Sohail Mehmood |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 22 Years |
| Location | 610 30th Ave W, Alexandria, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518280403 | NPI | - | NPPES |
| 1518280403 | Medicaid | MN | |
| 1518280403 | Other | MN | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 104737 (Minnesota) | Secondary |
| 208M00000X | Hospitalist | 104737 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alomere Health | Alexandria, MN | Hospital |
| St Cloud Hospital | Saint cloud, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Douglas County Hospital | 0648171413 | 101 |
News Archive
Tinkering with a method they helped develop over the last few years, scientists have for the first time measured at the nanometer scale the characteristic patterns of folds that give proteins their three-dimensional shape in water.
The U.S. Food and Drug Administration today approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae type b.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
The International AIDS Vaccine Initiative's (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006.
› Verified 2 days ago
| Entity Name | Douglas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164424305 PECOS PAC ID: 0648171413 Enrollment ID: O20040115000387 |
News Archive
Tinkering with a method they helped develop over the last few years, scientists have for the first time measured at the nanometer scale the characteristic patterns of folds that give proteins their three-dimensional shape in water.
The U.S. Food and Drug Administration today approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae type b.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
The International AIDS Vaccine Initiative's (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sohail Mehmood, MD 610 30th Ave W, Alexandria, MN 56308-3426 Ph: (320) 763-5123 | Dr Sohail Mehmood, MD 610 30th Ave W, Alexandria, MN 56308-3426 Ph: (320) 763-5123 |
News Archive
Tinkering with a method they helped develop over the last few years, scientists have for the first time measured at the nanometer scale the characteristic patterns of folds that give proteins their three-dimensional shape in water.
The U.S. Food and Drug Administration today approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae type b.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
The International AIDS Vaccine Initiative's (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006.
› Verified 2 days ago
Alison F Chinn, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-5123 | |
Dr. Dustin Alexander Lorentz, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-5123 Fax: 320-763-5749 |